Lydall Announces First Quarter 2014 Financial Results

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lydall Announces First Quarter 2014 Financial Results

MANCHESTER, Conn., May 5, 2014 (GLOBE NEWSWIRE) -- LYDALL, INC. (NYSE: LDL ) today announced financial results for the first quarter ended March 31, 2014. Net sales were $125.2 million in the current quarter compared to $99.0 million in the first quarter of 2013. Organic net sales growth, which excludes the effect of acquisitions and foreign currency, was 7.3% in the first quarter of 2014. Net income was $3.7 million, or $0.22 per diluted share in the first quarter of 2014 compared to $4.5 million, or $0.26 per diluted share, in the first quarter of 2013. Excluding adjustments related to the acquisition of the Industrial Filtration business on February 20, 2014 ("Acquisition"), adjusted earnings were $0.40 per diluted share for the quarter ended March 31, 2014.

The Acquisition contributed $17.7 million in net sales and $0.8 million of operating income, including the negative impact of purchase accounting adjustments to cost of sales of $1.3 million in the quarter ended March 31, 2014. Transaction related costs associated with the Acquisition were $2.4 million in the first quarter of 2014 and recorded in corporate office expenses.

Below are financial highlights comparing Lydall's quarter ended March 31, 2014 ("Q1 2014") results to its quarter ended March 31, 2013 ("Q1 2013") results:

  • Net sales increased by $26.2 million, or 26.5%, compared to Q1 2013 as net sales increased 7.3% organically, 17.9% from the Acquisition and 1.3% from favorable foreign currency translation;
     
  • Gross margin decreased to 20.9%, compared to 21.6% in Q1 2013, driven by the impact of purchase accounting adjustments of $1.3 million related to the Acquisition, as all other segments reported improved gross margin;
     
  • Operating income was $7.6 million, or 6.1% of net sales, including $0.8 million of operating income from the Industrial Filtration segment, compared to $6.5 million, or 6.6% of net sales, in Q1 2013. The first quarter of 2013 included $1.8 million of income from a non-recurring pricing negotiation and customer project. Excluding transaction expenses and purchase accounting adjustments, adjusted operating income was $11.3 million, or 9.0% of net sales, in Q1 2014; and
     
  • Effective tax rate of 49.5% compared to 29.8% in Q1 2013, as Q1 2014 included discrete income tax charges of approximately $1.0 million, (or $0.06 per diluted share), primarily from non-deductible transaction expenses related to the Acquisition, and Q1 2013 included a discrete tax benefit of $0.5 million (or $0.03 per diluted share) related to the conclusion of U.S. federal income tax matters through 2009.

Cash balance was $51.1 million at March 31, 2014 compared to $75.4 million at December 31, 2013. The Acquisition was funded by borrowing of $60.0 million from the Company's $100 million amended credit facility, with the remaining purchase price funded from the Company's cash balance. The Company's consolidated leverage ratio was approximately 1.4 at March 31, 2014 (as defined in the amended credit facility), significantly below a maximum permitted ratio of 3.0.

Purchase accounting adjustments and transaction expenses in the first quarter of 2014 reduced the Company's consolidated operating income by approximately $3.6 million, operating margin by approximately 300 basis points and earnings per share by approximately $0.18 per diluted share (as noted in the following table).

Quarter ended March 31, 2014 Pre-Acquisition Industrial  
(in thousands, except per share data) Businesses Filtration Consolidated
Net sales  $ 107,570  $ 17,656  $ 125,226
       
Operating Income, as reported  $ 6,840  $ 786  $ 7,626
Purchase accounting adjustment  --   1,282  1,282
Transaction expenses  2,363  --   2,363
Operating Income, adjusted  $ 9,203  $ 2,068  $ 11,271
Operating margin, as reported 6.4% 4.5% 6.1%
Operating margin, adjusted 8.6% 11.7% 9.0%
       
Earnings per share, as reported      $ 0.22
Purchase accounting adjustment, net of tax of $403      $ 0.05
Transaction expenses, net of tax of $152      $ 0.13
Earnings per share, adjusted      $ 0.40

The Company expects transaction related expenses, purchase accounting adjustments and incremental amortization of intangible assets to be in the range of $0.8 million to $1.0 million in the second quarter of 2014.

The Thermal/Acoustical Fibers ("T/A Fibers") segment net sales increased by $4.6 million, or 16.4%, with automotive parts sales increasing by $2.5 million and the remainder from tooling net sales. Thermal/Acoustical Metals ("T/A Metals") segment net sales increased by $2.3 million, or 5.6%, compared to the first quarter of 2013, driven by higher automotive parts sales of $3.9 million, partially offset by lower tooling net sales of $1.7 million. Volume growth contributed to the increase in automotive parts net sales for T/A Fibers in North America and T/A Metals in North America and Europe. Net sales for the Performance Materials segment increased by $1.4 million, or 5.0%, primarily from improved market conditions for filtration products within the segment's European operations.  

Dale Barnhart, President and Chief Executive Officer, stated, "Overall, we are very pleased with our first quarter business results. All of our pre-acquisition reportable segments experienced sales growth of at least 5%, and in the aggregate, adjusted operating margin expanded approximately 200 basis points compared to the first quarter of 2013. We are encouraged by the improved demand in Europe for Performance Materials filtration products and T/A Metals automotive parts and continue to benefit from strong demand in North America for automotive parts.

"I am also very pleased with the reported sales and operating margin, excluding the purchase accounting adjustments, of our new Industrial Filtration segment as we continue the process of integrating this business into Lydall. Favorable demand for felt filtration media and filter bags used in industrial air filtration applications provided for net sales of $17.7 million in less than half a quarter. As we previously announced, we expect this acquisition to be accretive to Lydall's 2014 full-year earnings and free cash flow, inclusive of the impact of transaction expenses, purchase accounting adjustments and incremental amortization of intangible assets.  

"The Company's overall outlook going into the second quarter of 2014 remains positive as European and Asian markets have improved, and the Company is well positioned to capitalize on opportunities for sales growth as well as operating margin expansion."

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles ("GAAP"), the Company uses certain non-GAAP financial measures, including adjusted operating income, adjusted operating margin and adjusted earnings per share, which exclude transaction related costs and purchase accounting adjustments related to inventory step-up. The Company excluded the above items because they are outside of Lydall's normal operations. Additionally, organic net sales refers to sales calculated according to GAAP but excluding (1) sales from the acquired business and (2) the impact of foreign currency translation.  The Company excludes the effect of foreign currency translation from organic net sales because currency translation is not under management's control, is subject to volatility and can obscure underlying business trends, and excludes the effect of acquisitions and related items because the nature and size of acquisitions can vary dramatically from period to period and can also obscure underlying business trends and make comparisons of long-term performance difficult.

The Company believes that the use of non-GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecasts the Company's performance, especially when comparing such results to previous periods or forecasts.  Non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the corresponding GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

Conference Call

Lydall will host a conference call today at 4:30 p.m. Eastern Time to discuss results for its first quarter ended March 31, 2014 as well as general matters related to its businesses and markets. The call may be accessed at (888) 317-6016, from within the U.S., or (412) 317-6016, internationally. In addition, the audio of the call will be webcast live and will be available for replay on the Company's website at www.lydall.com in the Investor Relations' Section. A recording of the call will be available from 6:00 p.m. Eastern Time on May 5, 2014 through 9:00 a.m. Eastern Time, May 13, 2014 at (877) 344-7529, from within the U.S., or (412) 317-0088, internationally, pass code 10045316. Also, additional information including a presentation outlining key financial data supporting today's conference call can be found on the Company's website www.lydall.com under the Investors Relations' Section.

Lydall, Inc. is a New York Stock Exchange listed company, headquartered in Manchester, Connecticut with global manufacturing operations producing specialty engineered products for the thermal/acoustical and filtration/separation markets. For more information, visit http://www.lydall.com . Lydall ® is a registered trademark of Lydall, Inc. in the U.S. and other countries. 

Cautionary Note Concerning Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact, including statements about the expected impact of the Acquisition on Lydall's future financial performance and estimated future transaction expenses, purchase accounting adjustments and amortization of intangible assets, and overall outlook for the second quarter of 2014, may be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management's current expectations for the future operating and financial performance of the Company based on current expectations and assumptions relating to the Company's business, the economy and other future conditions. Forward-looking statements generally can be identified through the use of words such as "believes," "anticipates," "may," "should," "will," "plans," "projects," "expects," "estimates," "forecasts," "predicts," "targets," "prospects," "strategy," "signs," and other words of similar meaning in connection with the discussion of future operating or financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Such risks and uncertainties include, among others, worldwide economic cycles that affect the markets that the Company's businesses serve which could have an effect on demand for the Company's products and impact the Company's profitability, challenges encountered by Lydall in the integration of the acquired businesses, disruptions in the global credit and financial markets, including diminished liquidity and credit availability, swings in consumer confidence and spending, unstable economic growth, raw material pricing and supply issues, fluctuations in unemployment rates, and increases in fuel prices, which could cause economic instability and could have a negative impact on the Company's results of operations and financial condition. Accordingly, the Company's actual results may differ materially from those contemplated by these forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our filings with the Securities and Exchange Commission, including the risks and uncertainties identified in Part I, Item 1A - Risk Factors of Lydall's Annual Report on Form 10-K for the year ended December 31, 2013. 

These forward-looking statements speak only as of the date of this press release, and Lydall does not assume any obligation to update or revise any forward-looking statement made in this press release or that may from time to time be made by or on behalf of the Company. Information may also be obtained from the Company Contact: David D. Glenn, Director of Business Development and Investor Relations, One Colonial Road, Manchester, CT 06042; Telephone 860-646-1233, email:  investor@lydall.com .

Summary of Operations    
In thousands except per share data    
(Unaudited)    
  Quarter Ended
  March 31,
  2014 2013
     
Net sales  $ 125,226  $ 99,029
Cost of sales  99,027  77,664
Gross profit  26,199  21,365
     
Selling, product development and administrative expenses  18,573  14,848
Operating income  7,626  6,517
     
Interest expense  212  78
Other expense, net  55  42
Income before income taxes  7,359  6,397
     
Income tax expense  3,643  1,905
Net income  $ 3,716  $ 4,492
     
Earnings per share:    
Basic  $ 0.22  $ 0.27
Diluted  $ 0.22  $ 0.26
     
Weighted average number of common shares outstanding 16,542 16,752
Weighted average number of common shares and equivalents outstanding 16,852 17,036
     
     
Summary of Segment Information and Other Products    
and Services    
In thousands    
(Unaudited) Quarter Ended
  March 31,
  2014 2013
Net Sales    
     
Performance Materials Segment  $ 28,853  $ 27,483
Industrial Filtration Segment  17,656  -- 
Thermal/Acoustical Metals Segment  42,456  40,202
Thermal/Acoustical Fibers Segment  32,513  27,927
Other Products and Services:    
Life Sciences Vital Fluids  4,724  4,307
Eliminations and Others  (976)  (890)
Consolidated Net Sales  $ 125,226  $ 99,029
     
Operating Income    
     
Performance Materials Segment  $ 1,863  $ 1,277
Industrial Filtration Segment  786  -- 
Thermal/Acoustical Metals Segment  3,653  3,018
Thermal/Acoustical Fibers Segment  7,341  6,154
Other Products and Services:    
Life Sciences Vital Fluids  420  356
Corporate Office Expenses  (6,437)  (4,288)
Consolidated Operating Income  $ 7,626  $ 6,517
     
     
     
     
Financial Position    
In thousands except ratio data March 31, 2014 December 31, 2013
(Unaudited)    
Cash and cash equivalents  $ 51,128  $ 75,407
Working capital  $ 144,811  $ 123,577
Total debt  $ 61,554  $ 1,714
Stockholders' equity  $ 204,263  $ 200,087
Total capitalization  $ 265,817  $ 201,801
Current ratio  3.0  3.5
Total debt to total capitalization 23.2% 0.8%
     
     
     
     
Cash Flows    
In thousands Quarter Ended
(Unaudited) March 31,
  2014 2013
     
Net cash used for operating activities  $ (2,860)  $ (3,217)
Net cash used for investing activities  $ (81,964)  $ (2,463)
Net cash provided by financing activities  $ 60,014  $ 196
Depreciation and amortization  $ 3,848  $ 3,345
Capital expenditures  $ (2,807)  $ (2,463)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Poland's Economic Boom: A Case for Freedom and Growth

Updated Category News Views 74

Poland's Remarkable Journey to Economic Power Freedom, they say, fuels progress—and Poland stands as a pulsating testament to that very idea. Thirty-odd years ago, shedding the chains of Soviet-imposed communism, Poland was all systems go, taking the wheel of its own destiny. For the first time, Polish innovation and industry were unleashed, paving the road toward...

Continue Reading
Bramshill Fund Takes Top Spot in 2026 Fund Awards

Updated Category News Views 32

Another Feather in Bramshill's Cap They've done it again, folks. The Bramshill Multi-Strategy Income Fund has just snagged the 40 Act Fund of the Year award at the 2026 Hedge Fund Performance Awards. This ain't just another plaque for the wall; it's a nod to some serious heavy lifting by the folks handling this beast of a portfolio. The award, dished out by With...

Continue Reading
Sino Biological Boosts AI Protein Discovery Efficiency

Updated Category News Views 37

Dissecting the Bridge Between AI and Biology In the cutthroat world of biotech, every second counts. Sino Biological is taking a good hard look at bridging AI and practical applications with their shiny new 4RISE™ solution. The stakes couldn't be higher—turning computer-generated protein ideas into lab-tested realities is no small feat. And believe me, researchers...

Continue Reading
Full Sail's Reach Expands with Film School Honor

Updated Category News Views 39

Full Sail's Cinematic Spotlight Moment Alright, folks, you're hearing it right: Full Sail University's caught the spotlight in TheWrap Magazine's annual who's-who of film schools for 2026. That's a pat on the back any educational institution would kill for, highlighting that Full Sail is playing with the big boys when it comes to film education. Beyond Classic Classroom...

Continue Reading
Alyssa Bunch: Big Moves in Tennessee Real Estate

Updated Category News Views 104

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Continue Reading
RLX Technology Gears Up for Q3 Earnings Call Ahead

Updated Category News Views 150

Under the Microscope: RLX Q3 2026 Earnings Get ready, because November 20 is shaping up to be a real event for RLX Technology watchers. The e-vapor heavyweight is gonna drop its Q3 results right before the crack of dawn U.S. markets open. Now, that's a time that stirs more coffee pots than debates—at 7:00 AM Eastern Time, to be precise. So, you better be braced for some...

Continue Reading
GCC's Path to 10 Gbps: U6GHz Revolution Unfolds

Updated Category News Views 96

On the Journey to 10 Giga: The U6GHz Leap You know, sometimes the telco world kicks up a fuss about speed, and this time, it’s the upper 6 GHz (or U6GHz) band that’s got everyone abuzz. At the Telecom Review Leaders' Summit in Dubai, industry bigwigs gathered to discuss how this spectrum could catapult the GCC into the 10 Gbps connectivity stratosphere. Fancy-talk...

Continue Reading
DentScribe Smashes AI Perio Chart Test with Perfect Score

Updated Category News Views 95

High Stakes in Dental Tech: DentScribe's Impeccable Show The dental tech world just got a jolt, and it's not from your morning coffee. DentScribe, the brains cooking up some AI magic in Sunnyvale, has unleashed a real heavyweight. They dropped the mic on their Periodontal Charting Benchmark 1.0 by acing 68 out of 68 tests without breaking a sweat—literal perfection in...

Continue Reading
Suiteify Teams Up With Findity for German Launch

Updated Category News Views 85

Striking a Partnership That Makes Sense Today's deal rolls in like thunder on a quiet afternoon. Suiteify, the master of HR and business software in the DACH region, hooks up with Findity to unleash a new game-changer in Germany. They’re cooking up Suiteify Expense & Travel, and if you're in the mid-sized business space, it’s worth a pause to see how these two horses...

Continue Reading
2026 Chinese Congress to Advance Integrative Oncology

Updated Category News Views 98

Changsha Set to Host a Global Convergence in Oncology For those interested in the blend of age-old wisdom and cutting-edge science, it’s time to tune into what’s happening in Changsha, China. The 2026 Chinese Congress on Holistic Integrative Oncology is about to kick off from November 12 to 15, and it's got quite the lineup of star-studded brainpower in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Bon Secours Mercy Health Collaborates on New Cardiac Facility

Updated Category News Views 156

A New Era in Cardiovascular Care In an exciting development for cardiovascular health services, Bon Secours Mercy Health, AlignedCardio, and Compass Surgical Partners have joined forces to establish a cutting-edge cardiovascular surgery center. This center, named the Short Pump Cardiovascular Ambulatory Surgery Center, is slated to open its doors in late 2025. The new...

Continue Reading
Fluence Energy Faces Investigation Over Securities Issues

Updated Category News Views 217

Fluence Energy Under Scrutiny for Potential Securities Fraud Pomerantz LLP is proactively investigating claims on behalf of investors linked to Fluence Energy, Inc. (NASDAQ: FLNC). This investigation aims to determine whether Fluence, along with its officers and directors, have participated in any unlawful business practices or securities fraud that could affect its...

Continue Reading
Oramed Pharmaceuticals Enters $11.5 Million Clinical Trial Deal

Updated Category News Views 243

Oramed Pharmaceuticals Inc. (NASDAQ: ORM) landed a key deal back in 2024 with InClin, Inc., a clinical research outfit that could shift the gears on their clinical trials. This agreement is meant to fuel Oramed's Phase 3 clinical trial efforts, as detailed in their filing. The stakes are high here; we’re talking about an oral insulin capsule aimed at type 2...

Continue Reading
Charles El-Moussa Joins MRED as General Counsel

Updated Category News Views 122

Charles El-Moussa Joins MRED as General Counsel Midwest Real Estate Data (MRED) has officially announced that Charles El-Moussa is stepping in as the company’s new General Counsel, effective immediately. A Strategic Move for MRED El-Moussa's appointment is a significant and strategic step for MRED. He will play a crucial role in providing legal guidance as the company...

Continue Reading
Caristo Diagnostics Celebrates Recognition for Cardiac Technology

Updated Category News Views 75

Caristo Diagnostics Triumphs in Digital Health Awards Caristo Diagnostics, a pioneering entity in the field of cardiovascular disease diagnostics and risk prediction, has recently celebrated a significant achievement. The company was awarded the prestigious Digital Health Hub Foundation's Digital Health Awards, where it was acknowledged as a 'Rising Star' in the Provider...

Continue Reading